Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 82.05
-7.05 (-7.91%)
Oct 22, 2026, 2:05 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 142.84 billion as of October 21, 2026. It is the 1,247th most valuable company in the world and the 62nd biggest in Hong Kong. Its market cap has decreased by 4.08% in one year.
Market Cap
142.84B
Enterprise Value
122.43B
Revenue
18.13B
Global Rank
Country Rank
#62 Hong Kong
PE Ratio
102.13
ChartMarket Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 142.84B, an increase of 670.50%. That is a compound annual growth rate of 29.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 142.84B | 8.00% |
| Dec 31, 2025 | 132.27B | 120.60% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 329.32B |
| WuXi Biologics | 197.80B |
| Sichuan Kelun-Biotech Biopharmaceutical | 108.04B |
| Sino Biopharmaceutical | 93.50B |
| Akeso | 84.10B |
| Genscript Biotech | 75.94B |
| RemeGen | 55.18B |
| Biocytogen Pharmaceuticals (Beijing) | 39.34B |